Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, irreversible, progressively destructive lung disease that culminates in respiratory failure and death. Randomised controlled trials have demonstrated that treatment of IPF patients with pirfenidone reduces lung function decline, improves progression-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cottin, Vincent, Maher, Toby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2015
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487763/
https://www.ncbi.nlm.nih.gov/pubmed/25726556
http://dx.doi.org/10.1183/09059180.00011514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487763/
https://www.ncbi.nlm.nih.gov/pubmed/25726556
http://dx.doi.org/10.1183/09059180.00011514

Ejemplares similares